Anna Wald
Professor (Tenured)
Department of Medicine, Division of Allergy & Infectious Diseases
Professor
Department of Epidemiology
Professor
Department of Laboratory Medicine & Pathology
Head, Division of Allergy and Infectious Diseases
Member, Vaccines & Infectious Diseases Division (VIDD), Fred Hutchinson Cancer Research Center
Director, UW Virology Research Clinic
Attending Physician
Sites of Practice: 
Harborview Medical Center
Seattle Cancer Care Alliance

Faculty Information

Biography
Honors: 
Phi Beta Kappa, Wesleyan University
1979
American Social Health Association Fellowship
1994
The Clinical Research Meeting Trainee Investigator Award
1995
University of Washington STD CRC New Investigator Award
1994
Fialkow Scholar Award
2000
ASTDA Achievement Award
2004
UW Medicine Award for Excellence in Mentoring Women and Minorities
2006
Association of American Physicians
2010
Award for Scientific Advancement, Association for Women in Science, Seattle
2014
WSCI Outstanding Investigator Award
2014
ASTDA Distinguished Career Award
2015
Contact
Phone: 
(206) 520-4340
Mailing Address: 

Harborview Medical Center
325 9th Ave
Box 359928

Seattle, WA 98104

Research & Clinical Interests
Research Interests: 
  • Herpesvirus infections
  • Clinical epidemiology
  • Clinical trials
  • Vaccine development
Clinical Interests: 
  • Clinical virology
  • Sexually transmitted diseases
  • Infections in immunocompromised host
Publications
Publications: 

Melvin AJ, Mohan KM, Schiffer JT, Drolette LM, Magaret A, Corey L, Wald A. Plasma and CSF herpes simplex virus levels at diagnosis and outcome of neonatal infection. J Pediatr. 2015 Apr; 166(4):827-33.
 PubMed Abstract

Rajagopal S, Magaret A, Mugo N, Wald A.  Incidence of herpes simplex virus type 2 infections in Africa: a systematic review. Open Forum Infect Dis. 2014 Jul 11; 1(2):ofu043.
 PubMed Abstract

Delaney S#, Gardella C, Saracino M, Magaret A, Wald A. Seroprevalence of herpes simplex virus type 1 and 2 among pregnant women, 1989-2010.  JAMA (Research Letter) 2014 Aug 20; 312(7):746-8.
 PubMed Abstract

Wald A, Corey L, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Kriesel J, Fife K, Galitz L, Stoelben S, Huang ML, Selke S, Stobernack HP, Ruebsamen-Schaeff H, Birkmann A. Helicase-Primase Inhibitor Pritelivir for Herpes Simplex Virus 2 Infection. N Eng J Med 2014; 370:201-210.
 PubMed Abstract

Perti T, Saracino M, Baeten J, Johnston C, Diem K, Ochbamichael N, Huang ML, Selke S, Magaret A, Corey L, Wald A. High-dose valacyclovir decreases plasma HIV-1 levels more than standard dose acyclovir in HIV-1, HSV-2 positive persons: a randomized, crossover trial. J Acquir Immune Dfic Syndr. 2013; 63(2):201-8.
• PubMed Abstract

Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet. 2012 Feb 18; 379(9816):641-7.
 Lancet Abstract